Hyperadrenocorticism in dogs: Treatment, follow-up, and complications;Hypercorticisme chez le chien: Mise au point sur la thérapeutique, suivi, complications

Point Veterinaire

Volumn 31, Issue Part 1, 2000, Pages 511-518

  Goy Thollot, I ^a   Cadore, J L ^a  

^a NONE

Author keywords

Adrenal; Dog; Domestic carnivores; Endocrinology; Hyperadrenocorticism; Medicines; Pituitary; Treatment

Indexed keywords

EID: 0034363476     PISSN: 03354997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. ANGLES JM, FELDMAN EC, NELSON RW et coll. Use of cortisol : creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in a dog. J. Amer. Vet. Med. Assn. 1997;211(8):1002-1004.
2. BARTHEZ PY, NYLAND TG, FELDMAN EC. Ultrasonographic evaluation of the adrenal gland in dogs. J. Amer. Vet. Med. Assn. 1995;207(9):1180-1183.
3. BEHREND EN, KEMPPAINEN RJ. Medical therapy of canine Cushing's syndrom. Comp. Cont. Educ. Pract. Vet. 1998;20(6):679-696.
4. BRUYETTE DS, RUEHL WW, ENTRIKEN T, GRIFFIN D, DARLING L. Management of canine pituitary-dependant hyperadrenocorticism with 1-Deprenyl (Anpryl). Vet. Clin. N. Amer. -Small Anim. Pract. 1997;27(2):273-285.
5. DUNN KJ, HERRTAGE ME, DUNN JK. Use of stimulation tests to monitor the treatment of canine hyperadrenocorticism. Vet. Record. 1995;137:161-165.
6. DUNN KJ. Complications associated with the diagnosis and management of canine hyperadrenocorticism. In Practice. 1997;5:246-255.
7. FELDMAN EC, MACK RE. Urine cortisolcreatinine ratio as a screening test for hyperadrenocorticism in dogs. J. Amer. Vet. Med. Assn. 1992;200(11):1637-1641.
8. nd éd. Philadelphia : W B Saunders Company, 1996; 186-266
9. FELDMAN EC, NELSON RW, FELDMAN MS. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs. J. Amer. Vet. Med. Assn. 1996;209(4):772-775.
10. FORD SL, FELDMAN EC, NELSON RW. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs : Four cases (1983-1988). J. Amer. Vet. Med. Assn. 1993;202(5):789-792.
11. FORRESTER SD, TROY GC, DALTON MN et coll. Retrospective evaluation of urinary tract infection in 42 dogs with hyperadrenocorticism or diabetes mellitus or both. J. Vet. Intern. Med. 1999;13:557-560.
12. GUPTILL L, SCOTT-MONCRIEFF JC, WIDMER WR. Diagnosis of canine hyperadrenocorticism. Vet. Clin. N. Amer. -Small Anim. Pract. 1997;27(2):215-233.
13. GUPTILL L, SCOTT-MONCRIEFF JC, BOTTOMS G et coll. Use of urine cortisol creatinine ratio to monitor treatment response in dogs with pituitary-dependent hyperadrenocorticism. J. Amer. Vet. Med. Assn. 210(8): 1158-1161
14. GRECO DS, PETERSON ME, DAVIDSON AP et coll. Concurrent pituitary and adrenal tumors in dogs with hyperadrenocorticism : 17 cases (1978-1995). J. Amer. Vet. Med. Assn. 1999;214(9):1349-1353.
15. nd éd. by Torrance AG& Mooney C.T. BSAVA Publications. 1998;55-75.
16. HESS RS, KASS PH, WARD CR. Association between hyperadrenocorticism and development of calcium-containing uroliths in dogs with urolithiasis. J. Amer. Vet. Med. Assn. 1998;212(12):1889-1891.
17. HERST BERTOY E, FELDMAN EC, NELSON RW et coll. One-year follow-up evaluation of magnetic resonance imaging of the brain in dogs with pituitary-dependent hyperadrenoorticism. J. Amer. Vet. Med. Assn. 1996;208(8):1268-1273.
18. HOERAUF A, REUSCH C. Ultrasonographic characteristics of both adrenal glands in 15 dogs with functional adrenocortical tumors. J. Amer. Anim. Hosp. Assn. 1999;35:193-199.
19. HUANG HP, YANG HL, LIANG SL et coll. Iatrogenic hyperadrenocorticism in 28 dogs. J. Amer. Anim. Hosp. Assn. 1999;35:200-207.
20. IHLE SL. Pituitary corticotroph macrotumors, diagnosis and treatment. Vet. Clin. N. Amer. -Small Anim. Pract. 1997;27(2):287-295.
21. JENSEN AL, IVERSEN L, KOCH J, HOIER R KY et coll. Evaluation of the urinary cortisol:creatinine ratio in the diagnosis of hyperadrenocorticism in dogs. J. Small Anim. Pract. 1997;38:99-102.
22. KERL ME, PETERSON ME, WALLACE MS et coll. Evaluation of low-dose synthetic adrenocorticotropic hormone stimulation test in clinically normal dog and dogs with naturally developing hyperadrenocorticism. J. Amer. Vet. Med. Assn. 1999;214(10):1497-1501.
23. KEMPPAlNEN RJ, BEHREND E. Adrenal physiology. Vet. Clin. N. Amer. -Small Anim. Pract. 1997;27(2):173-185.
24. KINTZER PP, PETERSON ME. Mitotane (op'-DDD) treatment of 200 dogs with pituitary-dependant hyperadrenocorticism. J. Vet. Intern. Med. 1991;5:182-190.
25. KINTZER PP, PETERSON ME. Mitotane treatment of 32 dogs with cortisol-secretingadrenocortical neoplamsms. J. Amer. Vet. Med. Assn. 1994;205:54.
26. KINTZER PP, PETERSON ME. Diagnosis and management of canine cortisol-secreting adrenal tumors. Vet. Clin. N. Amer. -Small Anim. Pract. 1997;27(2):299-307.
27. MACK RE, FELDMAN EC, WILSON SM. Diagnosis of hyperadrenocorticism in dogs. Comp. Cont. Educ. Pract. Vet. 1994;16(3):311-347.
28. MEIJ BP, VOORHOUT G, INGH TS et coll. Results of transsphenoidal hypophysectomy in 52 dogs with pituitary-dependent hyperadrenocorticim. Vet. Surgery. 1998;27:246-261.
29. MEIJ BP. Hypophysectomy in dogs : a review. Vet. Quart. 1999;21:134-141.
30. NICHOLS R. complications and concurrent disease associated with canine hyperadreriocorticism, Vet. Clin. N. Amer. -Small Anim. Pract. 1997;27(2):309-319.
31. ORTEGA TM, FELDMAN EC, NELSON RW et coll. Systemic arterial blood pressure and urine protein/creatinine ratio in dogs with hyperadrenocorticism. J. Amer. Vet. Med. Assn. 1996;209(10):1724-1729.
32. PETERSON ME, KINTZER PP. Medical treatment of pituitary-dependent hyperadrenocorticism, Mitotane. Vet. Clin. N. Amer. -Small Anim. Pract. 1997;27(2):255-271.
33. PETERSON ME. Medical treatment of pituitary-dependent hyperadrenocorticism in dogs: should L-Deprenyl (Anipryl) ever be used ? J. Vet. Intern. Med. 1999;13:289-290.
34. RANDOLPH JF, TOOMEYJ, CENTER SA et coll. Use of the urine cortisol-to-creatnine ratio for monitoring dogs pituitary-dependent hyperadrenocorticism during induction treatment with Mitotane (op'-DDD). Am. J. Vet. Res. 1998;59(3):258-261.
35. REUSCH CE, STEFFEN T, HOERAUF A. The efficacy of L-Deprenyl in dogs with pituitary-dependent hyperadrenocorticism. J. Vet. Intern. Med. 1999;13:291-301.
36. SOLTER PF, HOFFMANN WE, HUNGERFORD LL et coll. Assessment of corticosteroid-induced alkaline phosphatase isoenzyme as a screening test for hyperadrenocorticism in dogs. J. Amer. Vet. Med. Assn. 1993;203(4):534-538.
37. TIDWELL AS, PENNINCK DG, BESSO JG. Imaging of adrenal gland disorders. Vet. Clin. N. Amer, -Small Anim. Pract. 1997;27(2):237-253.
38. THUROCZY J, SLUIJS FJ, KOOISTRA HS et coll. Multiple endocrine neoplasias in a dog : corticotrophic tumour, bilateral adrenocortical tumours, and pheochromocytoma. Vet. Quart. 1998; 20(2):56-61.
39. VONDEREN IK, KOOISTRA HS, RIJNBERK AD. Influence of veterinary care on the urinary corticoid : creatinine ratio in dogs. J. Vet. Intern. Med. 1998;12:431-435.
40. WIDMER WR, GUPTILL L. Imaging techniques for facilitating diagnosis of hyperadrenocorticism in dogs and cats. J. Amer. Vet. Med. Assn. 1995;206(12):1857-1864.